Details of the Drug

General Information of Drug (ID: DM847EM)

Drug Name

ABH001

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01749306) A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing. U.S. National Institutes ofHealth.